Merit Medical Systems is the lead sponsor of 7 current clinical trials in our USA and UK registers. 4 are recruiting patients now. The most common phase is Observational. The most-studied condition is Venous Stenosis.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
WRAP North America
NCT06807099 · Venous Stenosis, Venous Occlusion
|
Observational | Recruiting | 2025-07 | USA |
|
Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)
NCT06153667 · ClinicalTrials.gov ↗ · Uterine Fibroid
|
Observational | Recruiting | 2024-08 | UK, USA |
|
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
NCT06422871 · ClinicalTrials.gov ↗ · End Stage Renal Disease, Hemodialysis Access Failure
|
Observational | Recruiting | 2025-07 | USA |
|
US Post-Market Surveillance Study of the Surfacer System
NCT05050799 · ClinicalTrials.gov ↗ · Venous Disease
|
Observational | Recruiting | 2022-02 | USA |
|
Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)
NCT05062291 · ClinicalTrials.gov ↗ · Venous Stenosis, Venous Occlusion
|
Observational | Active, closed | 2022-06 | UK |
|
GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)
NCT05818150 · ClinicalTrials.gov ↗ · Knee Osteoarthritis
|
Not applicable | Active, closed | 2024-01 | UK, USA |
|
PREEMIE: Study for Treatment of PDA in Premature Infants
NCT06587282 · ClinicalTrials.gov ↗ · Patent Ductus Arteriosus (PDA)
|
Not applicable | Active, closed | 2025-03 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 6 | 4 |
| Clinical trials in UK | 3 | 1 |
A trial with sites in more than one country appears in each of those registers.
Merit Medical Systems is the lead sponsor of 7 current trials on ClinicalTrials.gov in our USA and UK registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 4 of its 7 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.